| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Adma Biologics, Inc. (ADMA) has 9 insiders with recent SEC Form 4 filings, including 15 buys and 1 sell. ADMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.26M | $19.00M | - | |
| Dir | 2.05M | $17.20M | - | |
| Dir | 488.9K | $4.11M | - | |
| COO | 446.2K | $3.75M | - | |
| CFO | 232.9K | $1.96M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2020 | Grossman Adam S64 | President And CEO | Buy | 6,000 | $3.04 | $18,259.90 | +0.9% | |
| Aug 10, 2020 | Mond James | EVP, CSO And CMO | Buy | 7,000 | $2.88 | $20,150.00 | +5.4% | |
| Mar 19, 2020 | Perceptive Advisors LLC51 | 10% Owner | Buy | 500,000 | $2.10 | $1,050,000.00 | +3.1% | |
| Feb 11, 2020 | Guiheen Lawrence P.64 | Director | Buy | 20,000 | $3.50 | $70,000.00 | +40.0% | |
| Feb 11, 2020 | Mond James | CSO And CMO | Buy | 4,285 | $3.50 | $14,997.50 | +24.0% | |
| Feb 11, 2020 | Lenz Brian | EVP, CFO | Buy | 7,142 | $3.50 | $24,997.00 | +28.6% | |
| Feb 11, 2020 | Grossman Adam S64 | President And CEO | Buy | 85,714 | $3.50 | $299,999.00 | +10.0% | |
| Feb 11, 2020 | Perceptive Advisors LLC51 | 10% Owner | Buy | 4,563,700 | $3.50 | $15,972,950.00 | +39.6% | |
| Feb 11, 2020 | Grossman Jerrold B68 | Director | Buy | 45,714 | $3.50 | $159,999.00 | +41.6% | |
| Jun 6, 2019 | Biotest Divestiture Trust | 10% Owner | Sell | 5,813,954 | $3.75 | $21,802,327.50 | -57.5% |